We are live on ! Find out more
Focus Partners Wealth

Focus Partners Wealth Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.5%
This Fund
S&P 500
This Quarter Est. Return
+1.32%
1 Year Est. Return
+20.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$38.5B
AUM Growth
+$7.12B
Cap. Flow
+$6.33B
Cap. Flow %
16.44%
Top 10 Hldgs %
22.36%
Holding
1,991
New
421
Increased
1,067
Reduced
327
Closed
97

Sector Composition

Rank Sector Weight
1 Technology 14%
2 Financials 7.35%
3 Consumer Discretionary 5.13%
4 Communication Services 4.08%
5 Healthcare 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BZFD icon
1826
BuzzFeed
BZFD
$94.1M
$37.5K ﹤0.01%
+14,040
New +$44.1K
FRGE
1827
DELISTED
Forge Global Holdings
FRGE
$37.2K ﹤0.01%
+2,668
New +$44K
TLRY icon
1828
Tilray
TLRY
$498M
$35.6K ﹤0.01%
2,677
+587
+28% +$8.61K
CIG icon
1829
CEMIG Preferred Shares
CIG
$6.18B
$35.3K ﹤0.01%
+19,946
New +$38.7K
SANA icon
1830
Sana Biotechnology
SANA
$913M
$34.8K ﹤0.01%
+21,376
New +$63.7K
PERF icon
1831
Perfect Corp
PERF
$197M
$32.2K ﹤0.01%
11,375
LYG icon
1832
Lloyds Banking Group
LYG
$89B
$31.1K ﹤0.01%
+11,451
New +$32.7K
NGD
1833
DELISTED
New Gold Inc
NGD
$31.1K ﹤0.01%
12,558
+100
+0.8% +$276
KPTI icon
1834
Karyopharm Therapeutics
KPTI
$161M
$31K ﹤0.01%
+3,055
New +$36.9K
HRTX icon
1835
Heron Therapeutics
HRTX
$86.9M
$30.6K ﹤0.01%
+20,000
New +$32.4K
DHF
1836
BNY Mellon High Yield Strategies Fund
DHF
$170M
$28K ﹤0.01%
+10,961
New +$28.6K
HBIO icon
1837
Harvard Bioscience
HBIO
$27M
$27.7K ﹤0.01%
+1,314
New +$30.2K
CURI icon
1838
CuriosityStream
CURI
$145M
$27.5K ﹤0.01%
+18,000
New +$34.7K
AAME icon
1839
Atlantic American Corp
AAME
$31.6M
$27.5K ﹤0.01%
18,335
IMMX icon
1840
Immix Biopharma
IMMX
$619M
$26.2K ﹤0.01%
11,900
NRDY icon
1841
Nerdy
NRDY
$109M
$25.1K ﹤0.01%
15,476
+17
+0.1% +$21
LAB icon
1842
Standard BioTools
LAB
$303M
$24.6K ﹤0.01%
14,055
+1,053
+8% +$1.96K
NKLA
1843
DELISTED
Nikola Corporation Common Stock
NKLA
$22.2K ﹤0.01%
18,680
+259
+1% +$739
AKBA icon
1844
Akebia Therapeutics
AKBA
$343M
$20.7K ﹤0.01%
+10,892
New +$18.9K
CMPX icon
1845
Compass Therapeutics
CMPX
$375M
$19.7K ﹤0.01%
+13,591
New +$22.6K
GALT icon
1846
Galectin Therapeutics
GALT
$223M
$19.7K ﹤0.01%
15,251
-1,483
-9% -$3.55K
NINE
1847
DELISTED
Nine Energy Service
NINE
$19.4K ﹤0.01%
17,315
OPEN icon
1848
Opendoor
OPEN
$3.71B
$19.1K ﹤0.01%
+12,303
New +$22.3K
DRIO icon
1849
DarioHealth
DRIO
$54.6M
$18.9K ﹤0.01%
1,202
XFOR icon
1850
X4 Pharmaceuticals
XFOR
$372M
$18.4K ﹤0.01%
+834
New +$13.3K

Similar funds

Focus Partners Wealth's Q4 2024 Portfolio in Review

As of Q4 2024, Focus Partners Wealth held 1,991 positions worth $38.5B, up 23% from $31.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Focus Partners Wealth deployed $6.33B of net new capital in Q4 2024, opening 421 new positions and adding to 1,067 existing holdings. Its largest new stake was CoStar Group: 613,141 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Netflix, an estimated $587M trimmed.

  • Focus Partners Wealth's largest Q4 2024 buy was CoStar Group: 613,141 shares worth $43.9M.
  • Focus Partners Wealth added most to Apple in Q4 2024, an estimated $439M increase.
  • Focus Partners Wealth's biggest Q4 2024 reduction was Netflix, cutting an estimated $587M.
  • Focus Partners Wealth fully exited Air Lease Corp in Q4 2024, selling an estimated $165M.
  • Focus Partners Wealth's ten largest holdings make up 22% of its $38.5B portfolio in Q4 2024.
  • Focus Partners Wealth opened 421 new positions and closed 97 in Q4 2024.
  • Focus Partners Wealth's portfolio value rose 23% quarter-over-quarter to $38.5B.

Based on Focus Partners Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.